Phase 2 study of safety and efficacy of nimotuzumab (theracim (R)) in pediatric patients with recurrent diffuse intrinsic pontine glioma (DIPG) Meeting Abstract
| Authors: | Bartels, U.; Wolff, J.; Gore, L.; Dunkel, I.; Allen, J.; Goldman, S.; Yalon, M.; Packer, R.; Korones, D.; Smith, A.; Cohen, K.; Kuttesch, J.; Strother, D.; Baruchel, S.; Kowalski, M.; Eric, B. |
| Abstract Title: | Phase 2 study of safety and efficacy of nimotuzumab (theracim (R)) in pediatric patients with recurrent diffuse intrinsic pontine glioma (DIPG) |
| Meeting Title: | 43rd Congress of the International Society of Paediatric Oncology |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 57 |
| Issue: | 5 |
| Meeting Dates: | 2011 Oct 28-30 |
| Meeting Location: | Auckland, New Zealand |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2011-10-01 |
| Start Page: | 813 |
| Language: | English |
| ACCESSION: | WOS:000295239600430 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: PM038 - "Source: Wos" |
MSK Authors
-
371Dunkel